background
background
BMRN
Biomarin Pharmaceuticals
$56.82
+0.50
+0.89%
Earnings Expectation?
Beat
Meet
Miss
Expected Price Action?
Up
Flat
Down
Wednesday
February 19, 2025
4:05 PM ET
BioMarin Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Guidance
Wednesday
February 5, 2025
9:00 AM ET
BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET
Tuesday
October 29, 2024
4:03 PM ET
BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook
Wednesday
October 16, 2024
8:30 AM ET
BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET